Skip to main content
OpenTrials

Clinical trial condition

HIV-1-infection

Explore clinical trials studying HIV-1-infection. Study availability and eligibility vary by location and protocol.

230 public trials 34 recruiting studies
Refine in advanced search Browse all conditions

HIV-1-infection trial results

Active, Not Recruiting

Study to Compare an Oral Weekly Islatravir/Lenacapavir Regimen With Standard of Care in Virologically Suppressed People With HIV-1

NCT06630299

Conditions
HIV-1-infection
Locations
  • University of Alabama at Birmingham(UAB) 1917 Research Clinic Birmingham, Alabama, United States
  • Pueblo Family Physicians Phoenix, Arizona, United States
  • Vv-Tmf-5366229 Los Angeles, California, United States
  • Ruane Clinical Research Group Los Angeles, California, United States
View all 100 locations
View Trial Details
Active, Not Recruiting

Study to Compare an Oral Weekly Islatravir/Lenacapavir Regimen With Bictegravir/Emtricitabine/Tenofovir Alafenamide in Virologically Suppressed People With HIV-1

NCT06630286

Conditions
HIV-1-infection
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • Pueblo Family Physicians Phoenix, Arizona, United States
  • Kaiser Permanente Southern California Los Angeles, California, United States
  • Ruane Clinical Research Group, Inc Los Angeles, California, United States
View all 106 locations
View Trial Details
Active, Not Recruiting

Study of Oral Weekly Lepetegravir (Formerly GS-1720) and Lenacapavir Pacfosacil (Formerly GS-4182) Versus Biktarvy in People With HIV-1 Who Are Virologically Suppressed

NCT06544733

Conditions
HIV-1-infection
Locations
  • UAB 1917 Research Clinic Birmingham, Alabama, United States
  • Pacific Oaks Medical Group Beverly Hills, California, United States
  • Ruane Clinical Research Group Los Angeles, California, United States
  • Mills Clinical Research Los Angeles, California, United States
View all 39 locations
View Trial Details
Active, Not Recruiting

Pausing Antiretroviral Treatment Under Structured Evaluation

NCT06031272

Conditions
HIV-1-infection
Locations
  • Gaborone CRS (12701) Molepolole, Botswana
  • Blantyre CRS (30301) Blantyre, Malawi
  • Lilongwe Malawi CRS (12001) Lilongwe, Malawi
  • Ward 21 CRS (31966) Johannesburg, Gauteng, South Africa
View Trial Details
Active, Not Recruiting

Study to Evaluate the Safety and Efficacy of Lenacapavir (GS-6207) in Combination With an Optimized Background Regimen (OBR) in Heavily Treatment Experienced Participants Living With HIV-1 Infection With Multidrug Resistance

NCT04150068

Conditions
HIV-1-infection
Locations
  • Ruane Clinical Research Group Inc Los Angeles, California, United States
  • Mills Clinical Research Los Angeles, California, United States
  • Eisenhower Health Center at Rimrock Palm Springs, California, United States
  • One Community Health Sacramento, California, United States
View all 75 locations
View Trial Details
Active, Not Recruiting

A Study to Evaluate the Safety and Immunogenicity of the V3-region Directed Immunogens DV700P-RNA Followed by DV701B1.1-RNA in Adults Without HIV

NCT06919016

Conditions
HIV-1-infection
Locations
  • University of Alabama Medical Center (Site ID: 31788) Birmingham, Alabama, United States
  • The Hope Clinic of the Emory Vaccine Center CRS (Site ID: 31440) Decatur, Georgia, United States
  • Brigham and Women's Hospital (Site ID: 30007) Boston, Massachusetts, United States
  • Columbia P&S CRS (Site ID: 30329) New York, United States
View Trial Details

Related conditions